Similar articles

• [Multicentric study with perhexiline maleate in angina pectoris. Preliminary report].

  Nogueira A, Bozza A, Britto AH, Santos DV, Piero EF, Gomes FJ, Brito FS, Laffront G, Dohmann HF, Arroyo JB, et al. Nogueira A, et al. Arq Bras Cardiol. 1976 Dec;29(6):509-20. Arq Bras Cardiol. 1976. PMID: 798573 Clinical Trial. Portuguese. No abstract available.
• Proceedings: A comparative study of perhexiline, beta-adrenergic blocking agents and placebos in the management of angina pectoris.

  Armstrong ML. Armstrong ML. Postgrad Med J. 1973 Apr;49:Suppl 3:108-12. Postgrad Med J. 1973. PMID: 4587026 Clinical Trial. No abstract available.
• [Perhexiline maleate in the treatment of angina pectoris - double blind study].

  Cunha GP, Lopes M, Maranhão MF, Oliveira PF, Rojas RI. Cunha GP, et al. Arq Bras Cardiol. 1975 Jun;28(3):379-37. Arq Bras Cardiol. 1975. PMID: 1101858 Clinical Trial. Portuguese. No abstract available.
• [Cirrhogenic hepatitis due to perhexiline maleate: general review based upon one new case with ultrastructural study (author's transl)].

  Bertrand L, Baldet P, Blanc F, Puyeo J. Bertrand L, et al. Ann Med Interne (Paris). 1978 Oct;129(10):565-74. Ann Med Interne (Paris). 1978. PMID: 369426 Review. French.
• Is perhexiline essential for the optimal management of angina pectoris?

  Horowitz JD, Button IK, Wing L. Horowitz JD, et al. Aust N Z J Med. 1995 Apr;25(2):111-3. doi: 10.1111/j.1445-5994.1995.tb02820.x. Aust N Z J Med. 1995. PMID: 7605290 Review. No abstract available.